NIAMS to Fund Small Business Grants for Multiplex Assay Projects | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institute of Arthritis and Musculoskeletal and Skin Diseases aims to fund small businesses developing new multiplex diagnostic technologies that target biomarkers for a range of diseases.

NIAMS plans to provide Small Business Innovation Research grants of $150,000 for phase I projects and $1 million for phase II efforts to businesses developing multiplex tools for measuring multiple protein, DNA, or RNA-based biomarkers that can be detected in small volumes of fluid or biopsies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This Week in Science: New research into the emergence of infectious diseases, and scientists report on proteins involved in melanoma.

The hashtag #stupidcommonnames is gaining fans among scientists who find the common names of some animals and plants dumb.

Fed up with budget slashes, job cuts, and muzzling mandates, researchers in Canada are making science a campaign issue in the upcoming elections.

A former NIH program officer says the Internet has blasted open the door for scientific publications more interested in dollars than quality research.